. "Retraction: Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis." PLoS ONE, 2025. doi:10.1371/journal.pone.0339098